@kfoncology.bsky.social
Reposted
Ocular Toxicity Management and Early FRα Testing Are Key to Maximizing Efficacy of Mirvetuximab Soravtansine in Ovarian Cancer
#gynsm #oncology #MedEd #MedTwitter
www.onclive.com/view/ocular-...
#gynsm #oncology #MedEd #MedTwitter
www.onclive.com/view/ocular-...
Ocular Toxicity Management and Early FRα Testing Are Key to Maximizing Efficacy of Mirvetuximab Soravtansine in Ovarian Cancer
Ritu Salani, MD, discusses the role of mirvetuximab soravtansine in ovarian cancer and the need for specialist involvement in ocular toxicity management.
www.onclive.com
December 18, 2024 at 8:06 PM
Ocular Toxicity Management and Early FRα Testing Are Key to Maximizing Efficacy of Mirvetuximab Soravtansine in Ovarian Cancer
#gynsm #oncology #MedEd #MedTwitter
www.onclive.com/view/ocular-...
#gynsm #oncology #MedEd #MedTwitter
www.onclive.com/view/ocular-...